Ultra Violet Blood Irradiation (UVB), is also known as Photo-oxidation therapy, Photoluminescence, and Extracorporeal Photophoresis.  Ultra Violet Blood treatment consists of the insertion of a needle into a vein and the withdrawal of 60 or more cc's of blood that is passed through tubing where it is exposed to an ultraviolet light briefly.  The treated blood is then directly returned to the patient's bloodstream.  The only discomfort is during the insertion of the needle and is minimal.  The effects are long lasting and there is an absence of harmful side effects.  The simple treatments are easily combined with other medical procedures and are economical, dependable and gentle for the patient.

UVB is a biological healing modality utilizing ultraviolet irradiation of the blood to produce the following beneficial photochemical reactions:

• Improved micro circulation and oxygenation of tissues
• Anti-inflammatory effects
• Stimulation of the immune system
• Increased tolerance of the body towards radiation or chemotherapy
• Cardiovascular protection through increased metabolism of cholesterol, uric acid, and glucose
• Resolution of vascular spasms
• Powerful anti-infection properties

Historically, ultra violet blood therapy was first administered to humans in 1928 in Germany when a woman dying of sepsis ( a usually fatal bacterial infection of the blood) was cured in two days.  Currently, when use and over-use of antibiotics has produced super-strains of bacteria resistant to  more and more powerful (toxic) antibiotics, and new mutated strains of viruses are being identified every decade, ultra violet therapy is needed more than ever.  Medical research from American and German sources provides dozens of references on ultra violet blood therapy.  Those interested in further information can read Into the Light, by William Campbell Douglas, Second Opinion Publishing, Inc. 1993 for original references.

Indications for UVB:  When a patient has reached a plateau, UVB can often improve these patients further.  Indications include:  Infections of all types (bacterial, viral, fungal, protozoa), toxic conditions of all types - snake bites or organic poisoning, injuries, would healing, venous stasis ulcers, Raynaud's disease, migraine, acute flare ups of arthritic joints, fibromyalgia, osteoporosis pain, diabetic retinopathy, macular degeneration, asthma, acne, herpes zoster, psoriasis, chronic intestinal inflammation, occlusion of arteries (including stroke), thrombosis or increase in blood coagulability, thrombophlebitis, general detoxification.

Biological effects include:  Increase in:  arterial and venous oxygenation, blood pH, lymphocytes, electrical charge on the red blood cell, or bacteriocidal capacity of the blood, hemoglobin, white blood cell count, lymphocytes, phagocytosis ability; Reduction of:  cholesterol, creatinine levels, blood lactate, clot formation tendencies, blood viscosity, uric acid levels, fibrin levels, plasma viscosity, surface tension of the blood;  Normalization or modulation of:  immune status, glucose tolerance, and fibrinolysis.

Frequency of treatment:  Acute infectious situations typically will be treated with one treatment daily or every other day until improved or resolve.  Chronic situations are treated on a variable schedule, but a typical pattern of treatment  would be one treatment two times per week for three weeks, and then one treatment weekly for four weeks, then gradually moving towards one treatment every two months as maintenance.  The treatments may take effect immediately and the benefits are apparent for up to 45 days.

Contraindications include:  Porphyria, photosensitivity, acute hemorrhagic diseases (such as hemophilia-but not including routine medical anticoagulation), hyperthyroidism, subacute appendicitis and cholecystitis, immediately after a myocardial infarction (heart attack).